High Gene Therapy Costs Trigger Call for New Payment Models – Genetic Engineering & Biotechnology News
Bloomberg |
High Gene Therapy Costs Trigger Call for New Payment Models
Genetic Engineering & Biotechnology News The six-figure prices of new gene therapies will require payers, pharma companies, policymakers, and pharmacy benefit managers (PBMs) to develop new payment models that ensure patient access while reflecting the value delivered by the new treatments … Novartis's $475000 Price on Cancer Therapy Meets Resistance |
